Location History:
- San Diego, CA (US) (2005)
- Solana Beach, CA (US) (2006)
Company Filing History:
Years Active: 2005-2006
Title: Innovations by Matthew D Linnik
Introduction
Matthew D Linnik is a notable inventor based in Solana Beach, California. He has made significant contributions to the field of medical treatments, particularly in the area of autoimmune diseases. With a total of two patents to his name, Linnik's work focuses on innovative methods for treating lupus and related conditions.
Latest Patents
Linnik's latest patents include groundbreaking methods of treating lupus based on antibody affinity. This invention provides methods for identifying individuals suitable for lupus treatment and monitoring their progress through the measurement of antibody affinities. The treatment involves administering a conjugate that includes a non-immunogenic valency platform molecule and double-stranded DNA epitopes, which bind to anti-DNA antibodies present in the patient.
Another significant patent is related to therapeutic and diagnostic domain 1 β2GPI polypeptides and their applications. This invention offers domain 1 β2GPI polypeptides, polynucleotides encoding these polypeptides, and mimetics. These polypeptides are crucial for detecting β2GPI-dependent antiphospholipid antibodies, which are linked to various health issues, including thrombosis and fetal loss. The invention also outlines methods for inducing tolerance using these polypeptides.
Career Highlights
Matthew D Linnik is currently associated with La Jolla Pharmaceutical Company, where he continues to advance his research and innovations. His work has the potential to significantly impact the treatment of autoimmune diseases, providing new avenues for patient care.
Collaborations
Linnik has collaborated with notable colleagues, including David Matthew Marquis and Gilbert M Iverson. These partnerships have likely contributed to the development and refinement of his innovative ideas and patents.
Conclusion
Matthew D Linnik is a distinguished inventor whose work in the medical field has led to significant advancements in the treatment of lupus and related conditions. His innovative patents reflect a commitment to improving patient outcomes through scientific research and collaboration.